| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.68 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |